135 related articles for article (PubMed ID: 16110803)
1. Advances in diagnostic testing.
Verweij PE
Med Mycol; 2005 May; 43 Suppl 1():S121-4. PubMed ID: 16110803
[TBL] [Abstract][Full Text] [Related]
2. Critical assessment of issues in the diagnosis of invasive aspergillosis.
Klont RR; Meis JF; Verweij PE
Clin Microbiol Infect; 2001; 7 Suppl 2():32-7. PubMed ID: 11525216
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility and development of biomarkers in invasive aspergillosis.
Patterson TF
Trans Am Clin Climatol Assoc; 2011; 122():174-83. PubMed ID: 21686223
[TBL] [Abstract][Full Text] [Related]
4. [Aspergillosis].
Mori T; Yamamoto Y
Nihon Rinsho; 2010 Jun; 68 Suppl 6():280-3. PubMed ID: 20942058
[No Abstract] [Full Text] [Related]
5. Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.
White PL; Wingard JR; Bretagne S; Löffler J; Patterson TF; Slavin MA; Barnes RA; Pappas PG; Donnelly JP
Clin Infect Dis; 2015 Oct; 61(8):1293-303. PubMed ID: 26113653
[TBL] [Abstract][Full Text] [Related]
6. Galactomannan and Polymerase Chain Reaction-Based Screening for Invasive Aspergillosis Among High-Risk Hematology Patients: A Diagnostic Meta-analysis.
Arvanitis M; Anagnostou T; Mylonakis E
Clin Infect Dis; 2015 Oct; 61(8):1263-72. PubMed ID: 26157047
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
8. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis of invasive aspergillosis.
Hope WW; Walsh TJ; Denning DW
Lancet Infect Dis; 2005 Oct; 5(10):609-22. PubMed ID: 16183515
[TBL] [Abstract][Full Text] [Related]
10. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.
Fayemiwo S; Moore CB; Foden P; Denning DW; Richardson MD
J Microbiol Methods; 2017 Sep; 140():32-39. PubMed ID: 28645480
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic tests: Aspergillosis].
Mori T; Sugi Y
Nihon Rinsho; 2005 Jul; 63 Suppl 7():271-3. PubMed ID: 16111246
[No Abstract] [Full Text] [Related]
12. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.
Trof RJ; Beishuizen A; Debets-Ossenkopp YJ; Girbes AR; Groeneveld AB
Intensive Care Med; 2007 Oct; 33(10):1694-703. PubMed ID: 17646966
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
Ahmad S; Khan ZU; Theyyathel AM
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
15. Application of diagnostic markers to invasive aspergillosis in children.
Roilides E; Pana ZD
Ann N Y Acad Sci; 2012 Dec; 1272():1-8. PubMed ID: 23231708
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
[TBL] [Abstract][Full Text] [Related]
17. Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis.
Springer J; Lackner M; Nachbaur D; Girschikofsky M; Risslegger B; Mutschlechner W; Fritz J; Heinz WJ; Einsele H; Ullmann AJ; Löffler J; Lass-Flörl C
Clin Microbiol Infect; 2016 Jan; 22(1):80-86. PubMed ID: 26400571
[TBL] [Abstract][Full Text] [Related]
18. Diagnostics and susceptibility testing in Aspergillus.
Bernal-Martínez L; Alastruey-Izquierdo A; Cuenca-Estrella M
Future Microbiol; 2016; 11(2):315-28. PubMed ID: 26848512
[TBL] [Abstract][Full Text] [Related]
19. The current management landscape: aspergillosis.
Maertens JA; Blennow O; Duarte RF; Muñoz P
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii23-ii29. PubMed ID: 27880666
[TBL] [Abstract][Full Text] [Related]
20. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
